Posts with «health» label

Study finds surgery patients wearing VR headsets needed less anesthetic

More evidence is mounting that virtual reality might relieve pain during surgery. MIT Newsreports that Beth Israel Deaconess Medical Center researchers in Boston have published a study indicating that patients wearing VR headsets required less anesthetic during hand surgery. While the average conventional patient needed 750.6 milligrams per hour of the sedative propofol, people looking at relaxing VR content (such as meditation, nature scenes and videos) only required 125.3 milligrams. They also recovered earlier, leaving the post-anesthesia unit after 63 minutes on average versus 75 minutes.

The scientists claim VR distracted the patients from pain that would otherwise command their full attention. However, the researchers also admitted that the headset wearers may have gone into the operating room expecting VR to help, potentially skewing the results.

Beth Israel Deaconess' team is planning trials that could rule out this placebo effect, though. One follow-up trial will also gauge the effect of VR on patients receiving hip and knee surgery. Past experiments, such as at St. Jospeph's Hospital in France, have indicated that the technology can help assuage patients.

The allure for healthcare providers is clear. Patients might suffer less and return home sooner. Hospitals, meanwhile, could make the most of their anesthetic supplies, free recovery beds and reduce wait times. What a provider spends on VR headsets could pay for itself if it allows for more patients and higher-quality treatment.

The best fitness gear to upgrade your workout routine

Maybe you like to run, or perhaps you’re many years into a regular gym habit. You’ve dabbled with fitness wearables and thought about treating yourself to a massage gun, but never got around to buying one. Perhaps your foam roller is starting to crumble, and that free tee you got with protein powder has seen better days. You might be fitter, but your fitness equipment and tech are due for an upgrade.

The Engadget team has picked some of their favorite exercise tech purchases that have made our fitness journeys less of a struggle. From the best wearable tech to our favorite smart scale, some selections command premium prices, while a few are surprisingly affordable.

Oura Ring

Mat Smith / Engadget

As we said in our review, the Oura ring is a wearable for people who hate wearables. It also offers more robust sleep tracking than many watch-like devices. Despite the size and weight remaining unchanged from the second-gen Oura ring, it’s incredible how much technology is crammed into this thing. The third generation has sensors that can track your heart rate continuously; temperature monitoring; blood oxygenation; and period prediction.

The Oura ring is very serious about tracking everything it can. Given the lack of a display, you’ll need your smartphone to check on your recovery scores and how well you slept. These scores are synthesized from biometrics, including your heart rate variability, body temperature, resting heart rate and breathing rate. With a subscription – yes, something you may have to pay beyond the $299 asking price – you’ll get weekly summaries to show how your activity levels and sleeping hours are trending. I like Oura’s ability to tell when you’ve been training a little too hard and that the app suggests taking a day off to recover.

The ring isn’t perfect. The company has let some features drag for months – especially frustrating when some users pay a monthly sub. For example, blood oxygenation (SpO2) level tracking was promised when the third-gen Oura Ring was first announced and has only just arrived on most rings – almost half a year late.

A warning: If you’re planning to track weight lifting workouts with the Oura ring, the black edition is likely to show some conspicuous scratches if you’re gripping metallic bars and plates. I also struggled with pull-ups, as I’m not quite used to wearing a ring while gripping for my life. – Mat Smith, UK Bureau Chief

Buy Oura Ring - $299

Apple Watch Series 7

Cherlynn Low / Engadget

The most popular smartwatch series continues to lead on the feature front – if you ignore sleep tracking. The Series 7 has the biggest screen yet of any Apple Watch. It’s over 50 percent bigger than the Series 3 and 20 percent larger than the Series 6 that came before it. With more screen space and bigger buttons, it’s easier to stop and start workouts and check your heart rate and time elapsed during exercise. In addition, since watchOS 5, Apple’s wearables have been able to auto-detect specific workouts, which is great for when you forget to start logging a run or a spin session.

The Series 7 can track your VO2 Max levels, measuring your cardiorespiratory fitness level. What’s cool here is how the wearable notifies you when your levels tangibly change. So if you start a new intensive workout regime, you’ll see these figures creep up. Your iPhone will notify you when you make tangible improvements, say moving from below to above average cardio fitness levels, possibly even to its high fitness level. I’ve been hovering around 50 VO2 Max, but I’ll get to 52 eventually.

The Apple Watch also has its own connected workout platform in the form of Fitness+, offering HIIT, dance, pilates, yoga classes and more, streaming classes to your iPhone, iPad, Mac or Apple TV. Your heart rate will show on screen during many classes, indicating how you’re faring compared to other Fitness+ members and hopefully inspiring you to push a little harder. 

Of course, Apple Watch Series 8 (as well as a new 'pro' Ultra model) are both launching very soon. The Watch Ultra, in particular, packs longer battery life and a brighter screen — perfect for outdoor sports. – M.S.

Buy Apple Watch Series 7 at Amazon - $389

Theragun Prime

Mat Smith/Engadget

Theragun’s unique triangle design helps its devices stand out from a legion of other massage therapy guns. Multiple ways to grip the Theragun make it easier to target trickier body parts. As one of the more premium massage devices, it offers 16mm amplitude (typically only bested by devices several hundred dollars more) and speeds of up to 2,400 percussions per minute. Some health claims (like improved performance) are backed up by limited studies, but others (including sped-up muscle recovery) are not. I love using mine to target specifically tight areas; it even feels good ahead of a workout.

The Theragun Prime is better than most of the massage gun competition. It’s more flexible, too. Compared to Therabody’s own more basic options, the Prime comes with three extra attachments in addition to the standard ball: a cone, a dampener with a flattened head, and a thumb attachment, which can help dig deeper. The battery is thankfully long-lasting, too. – M.S.

Buy Theragun Prime at Amazon - $299

Eufy Smart Scale P1

Eufy

It’s time to throw away that chunky analog scale with the wobbly dial. Instead, for a more aesthetically pleasing design and deeper insight into your body weight and composition, it’s time to go digital. Several smart scale options are available, but I’ve used the sensibly priced Eufy Smart Scale P1. This smart scale connects with your smartphone to sync your data, and you just need to remember to open the app. Otherwise, it won’t track your progress.

It can monitor your weight in imperial or metric measurements and even make a rough guess at your body fat and water percentages. However, it’s worth noting that domestic smart scales are often not hugely accurate at gauging these measurements.

There are even more advanced smart scales too. Still, they are usually over double the price of the Smart Scale P1, often adding unnecessary features like multiple user profiles, Alexa voice activation, athletic modes for pro athletes and more. At some point, it’s diminishing returns, but the ability to digitally track (as well as set up weigh-in reminders) helped me form better habits to monitor my weight. – M.S.

Buy Smart Scale P1 at Amazon - $45

Beats Fit Pro earbuds

Mat Smith / Engadget

Many true wireless earbuds, let alone conventional headphones, weren’t made for working out. Some have non-removable parts that can get gunked up, while others lack water and dust resistance or have wires liable to tangle up or tug at you during workouts. For many of these reasons, I swear by true wireless earbuds and the Beats Fit Pro deliver on everything I want from workout buds. That includes active noise cancellation (less weight slamming and awful gym music), an understated profile, and a comfortable fit with a convenient fin design to lock it into your ear without making your ears ache.

Thankfully, they don’t stick out your ears like many earbud options. The company recently launched a series of even more subtle skin-colored buds in collaboration with Kim Kardashian. With Apple’s H1 chip, the Beats Fit Pro can offer hands-free Siri functionality and enhanced Find My item tracking. – M.S.

Buy Beats Fit Pro at Amazon - $200

On-demand fitness subscription

Peleton

One of the best things I've done for my fitness routine as of late is introducing some variety. Since I work out in the morning right after waking up, it's pretty easy for me to fall into a routine of doing the same thing over and over again. However, I've found it much easier to switch things up by relying on an on-demand fitness subscription.

I've tried a handful of the many services out there now, but the ones I've stuck with are Peloton and Alo Moves. I don't own a single piece of Peloton hardware; I instead spend $13 each month for app access only, and that's where I take most of my strength-training classes. I like that they're constantly putting out new offerings every day, but the backlog of on-demand classes is bursting at the seams, too. The sessions are challenging and engaging, and there are plenty of options if you don't have any equipment at all.

Alo Moves is more focused on yoga, pilates and barre, and it’s a bit more expensive at $20 per month. I'm more interested in toning than bulking up, so I try to incorporate some of these classes into my strength training routine. I particularly like that Alo Moves has a "series" of sessions that fall under the same umbrella that you can take over the course of many days. When I really don't want to think about what I'm doing on a given morning for a workout, it's easy just to turn to the next class in the barre series I was already working on. – Valentina Palladino, Senior Commerce Editor

Subscribe to Peloton app - $13/montthSubscribe to Alo Moves - $20/month

Bowflex Selectech adjustable dumbbells

Bowflex

For a lot of us, space is at a premium. We might have enough space to roll out a yoga mat, but not much more beyond that. Consolidating (and shrinking) your home workout gear is a nice way to keep your exercise habits going without tripping over weights or resistance band. Bowflex is a well-established fitness company that’s made adjustable dumbbells for several years now. The weight range will depend on the model, but the Bowflex SelectTech 552i can be dialed (literally) down to 2kg (4.4 pounds) and up to 24kg (53 pounds) each, making them suitable for all kinds of full-body and dedicated muscle group moves. A dial on each side of the weight adjusts how many plates the bar latches onto, with the remaining weight staying behind in the included storage tray.

There are several adjustable dumbbells out there, but I prefer this classic ‘dumbbell’ look compared to some of the more squarish-looking rivals. One minor issue is that you’ll have to tinker with both sides to adjust the weight. Also, if you’re looking for an on-demand workout service, Bowflex includes a free one-year subscription to its JRNY streaming service. – M.S.

Buy Bowflex SelectTech 552i at Amazon - $219

Withings has a new smart scale and 'Health+' fitness subscription platform

Withings is today announcing yet another in its range of class-leading smart scales, Body Comp. The device is pitched as a “complete body assessment scale” which can look at the sort of facets of our bodies normally reserved for clinical settings. That includes weight, muscle mass, fat mass, water percentage, bone mass, BMI and visceral fat counts. You’ll also get information on your standing heart rate and your vascular health (based on PulseWave Velocity), as well as analyzing your nerve health. And, of course, it’s the first Withings product that will be sold to be compatible with Health+, the company’s other new announcement.

Health+ is Withings’ new subscription platform, since recurring revenue is now the one way that most hardware businesses make money these days. It promises to “unlock additional features in the Health Mate app,” offering insights on how to strive for a better body. These include six week habit-forming modules, all of which is contextualized with the data offered by your Withings devices. They will also be offered meal plans and suggested workouts to help them achieve their goals faster. (Health+ will set you back $79.95 after the first year of use, and is only compatible so far with this and any future Withings' products.)

Now, this is actually a different product to Body Scan, the scale that Withings announced back in January which came with its own electrode handle. That, much like other high-end body composition scales, asks you to hold the handle at waist height in order to better read your vital statistics. Armed with the data, it’ll tell you the fat and water ratios in your arms, legs and torso, as well as monitoring your nerve activity. That product hasn’t actually hit stores yet, but it’s already clear that Body Comp will offer the bulk of the same features with a little less fine grain data.

There is now a significant number of devices that have Withings and Body in the name and you’d be forgiven for struggling to keep them all straight in your head. The existing flagship is the Body Cardio, which has all of the current bells and whistles, including weight, BMI, body composition, heart rate and vascular age. Below that, the Body+ offers weight, BMI and body comp, while the vanilla Body just offers weight and BMI.

Google Search and Maps results will confirm if a medical center offers abortions

In the wake of Roe v. Wade being overturned, Google announced that it is making it easier to use its Maps and Search products to find medical providers that offer abortions. When someone searches for specific services and Google has confirmation that a location provides those services, it'll be clearly labeled in Search and Maps. For example, Google notes that it already does this when you search for EV charging stations or a specific COVID-19 vaccine brand, and now it'll do so for veterans hospitals and healthcare facilities that provide abortions. As you can see in the above image, searching for "abortion clinics near me" will bring up a list of locations that Google has confirmed provide abortion services.

While Google isn't coming right out and saying it, this seems to be an effort to avoid sending people who are searching for medical care to so-called "abortion crisis centers" or anti-abortion centers. For locations that Google doesn't have confirmation for, it'll instead say "might not provide abortions," which serves as a passive but still significant red flag for anyone looking for treatment. In 2018, the Supreme Court ruled that anti-abortion centers couldn't be forced to acknowledge abortion as an option, something that outsources that work to private companies like Google. 

Earlier this week, Yelp announced it would take a similar but more definitive step by adding warning labels to anti-abortion centers; these warnings note that such facilities "may not have licensed medical professionals on site." Google says its update has been in the works for months, but it comes at a time where employees have said the company needs to do more to project both users and its contract workers in a post-Roe world.

The fact that Google is getting confirmation from centers that provide abortions should make both Search and Maps results more useful. A Google spokesperson said that "we get confirmation that places provide a particular service in a number of ways, including regularly calling businesses directly and working with authoritative data sources." So users should be able to trust that medical centers that are labeled as providing abortions do in fact offer the service. Google is also making it easy to expand your search if you don't find relevant results nearby with a "search farther away" prompt, another tool that can help people looking for abortion services where clinics are rare. 

Google says these changes will start rolling out today, though they won't immediately be visible to all Google users until a bit later.

Meta says it mistakenly restricted a Planned Parenthood post about abortion pills

Facebook parent company Meta says it by mistake recently removed a Planned Parenthood of Michigan post that included information on where to obtain abortion medication. “A medication abortion is a nonsurgical option for ending a pregnancy in the first trimester. Approved by the FDA for use up to roughly 10 weeks of pregnancy, these medications are highly effective with little risk of serious side effects,” the post said, according to Motherboard (via The Verge), with a link to a website outlining a list of providers.

An alert shared by Planned Parenthood of Michigan spokesperson Ashlea Phenicie said the post was restricted for violating Facebook’s guidelines. “The Community Standards apply to the world, and help keep Facebook safe and welcoming for everyone,” the notification stated.

Hey @facebook. Medication abortion is safe and legal in Michigan. You don’t need to help anti-abortion politicians restrict access any further. pic.twitter.com/aYcnkM9J2t

— Ashlea Phenicie (@Ashlea_Phenicie) August 19, 2022

Abortion is legal in Michigan. The removal occured after Meta admitted in June to “incorrect” moderation of posts about abortion pills. In the days after the Supreme Court’s June 24th decision to overturn Roe v. Wade,Motherboard found that the company had been flagging posts that said “abortion can be mailed.” According to Meta’s Community Standards, content discussing the affordability of prescription medication is allowed on Facebook, but users cannot use the platform to buy, sell, trade, gift, request or donate pharmaceuticals.

Yelp adds a warning label to anti-abortion center listings

Starting today, Yelp will apply a label to business pages for crisis pregnancy centers (also known as anti-abortion centers) to clarify that these facilities usually have limited medical services. The label also notes that crisis pregnancy centers "may not have licensed medical professionals onsite." The consumer notice could help people avoid confusion with clinics that offer abortion services.

In a blog post, Yelp said it was making the change following the US Supreme Court's decision in June to overturn Roe v. Wade, a ruling that conferred a nationwide right to safe abortion access for nearly 50 years. "The trust and safety of our community is a top priority, which is why providing consumers with reliable and useful information to help inform their decisions is critical to our mission — this includes access to reliable information about reproductive health services," Yelp wrote.

Yelp

Many crisis pregnancy centers have religious affiliations, as the Associated Presspreviously reported. Some are said to provide misleading information about abortion and contraception.

Yelp has reviewed tens of thousands of business listings since 2018 with the aim of ensuring crisis pregnancy centers are differentiated from abortion clinics. It noted that moderators have reclassified almost 470 businesses as crisis pregnancy centers or faith-based crisis pregnancy centers this year alone in the US, after reviewing nearly 33,500 business pages. It plans to review more than 55,000 business pages across the US, Canada and Puerto Rico in the coming months.

This is an issue that other tech companies have been contending with. Last week, the Alphabet Workers Union demanded that Google address "misleading search results related to abortion services by removing results for fake abortion providers." Democratic lawmakers have asked Google to stop directing people seeking an abortion to anti-abortion facilities, while some Republican attorneys general warned the company not to limit such centers from appearing in search results. In early July, Google said it would delete abortion clinic visits from user location histories.

Anthony Fauci's enduring impact on the AIDS crisis

After 38 years as the head of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci announced on Monday that he will be stepping down from his role in December. Appointed to the position in 1984 by then-president Ronald Reagan, Fauci has personally overseen the federal government’s response to some of the 20th century’s deadliest infectious diseases — from tuberculosis and COVID to SARS and MERS.

But, as he told The Guardian in 2020, “my career and my identity has really been defined by HIV.” The prevention and treatment of HIV has been a prioritized area of research for the NIAID since 1986, and one that Dr. Fauci has devoted much of his public service to. The current state of AIDS research and response in America is thanks in no small part to his continued efforts in the field.

The NIAID is one of 27 specialized institutes and centers that make up the National Institutes of Health (NIH), which in turn reports to the Department of Health and Human Services. The NIH overall serves as the federal government’s premiere health research program. The NIAID operates within that bureaucratic framework, conducting and supporting “basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases,” per its mission statement. That includes everything from working to mitigate effects of the annual influenza strain and alleviate asthma in urban youth to leading the development of an effective vaccine against COVID-19. The technology behind that vaccine is now being adapted for use against HIV and malaria as well.

Working at the forefront of immunoregulation research in the early 1980s, Fauci developed treatments for a class of otherwise-fatal inflammatory diseases including polyarteritis nodosa, granulomatosis with polyangiitis (formerly Wegener's granulomatosis) and lymphomatoid granulomatosis. The results of those studies helped lay the groundwork for today’s research by the NIAID’s Laboratory of Immunoregulation. That research includes cellular and molecular mechanisms of HIV immunopathogenesis and the treatment of immune-mediated diseases. Combining the institute’s nearly four decades of HIV/AIDS research with cutting edge genomic technology has brought us not one, but three potentially viable AIDS vaccines, all of which are currently in clinical trials.

“Finding an HIV vaccine has proven to be a daunting scientific challenge,” Dr. Fauci said in a March NIAID release. “With the success of safe and highly effective COVID-19 vaccines, we have an exciting opportunity to learn whether mRNA technology can achieve similar results against HIV infection.”

The active, hands-on approach we see in response to the AIDS epidemic today is a far cry from that of the Reagan administration at the start of the crisis in 1983, which initially met the issue with silence. That is, outside of the time Larry Speakes, Reagan's press secretary, called it “the gay plague.”

Fauci’s initial efforts during the AIDS epidemic did more harm than good. In 1983, he published The Acquired Immune Deficiency Syndrome: The Ever-Broadening Clinical Spectrum in which he warned of “the possibility that routine close contact, as within a family household, can spread the disease.” We know now that this is not at all how HIV works, but at the time — despite the study urging caution until more evidence was gathered — it set off a moral panic in the media. The study was subsequently picked up by right-wing organizations and used as a political cudgel blaming the LGBTQIA+ community for the disease.

Reagan himself didn’t publicly mention the crisis until 1985, three years after it was officially identified by the CDC (and, coincidentally, a month after he admitted his involvement in the Iran-Contra Scandal). Social stigma around the disease made funding for basic health research nearly impossible to acquire, and was exacerbated by Reagan’s repeated budget cuts to the NIH and CDC.

"The inadequate funding to date has seriously restricted our work and has presumably deepened the invasion of this disease into the American population," a CDC staffer wrote in an April, 1983 memo to then-Assistant Director, Dr. Walter Dowdle. "In addition, the time wasted pursuing money from Washington has cast an air of despair over AIDS workers throughout the country."

Even after his appointment as Chief Medical Officer — one who was determined to treat the AIDS crisis with its deserved gravity — Fauci faced pushback from the LGBTQIA+ community, who demanded greater action from the government in response to the crisis and sought to accelerate the glacial pace of drug trials at the time.

By 1990, the community’s patience had reached a breaking point, resulting in ACT UP’s (AIDS Coalition to Unleash Power) attempt to storm the NIH in protest. “One of the things that people in ACT UP said is that we are the people who are experiencing this novel disease, and we are the experts, not just the scientists and doctors,” Garance Ruta, executive director of GEN magazine and an ACT UP member at the protest, told The Washington Post in 2020.

“I was trying to get them into all the planning meetings for the clinical trials,” Fauci told WaPo, in response. “I felt very strongly that we needed to get them into the planning process because they weren’t always right, but they had very, very good input.”

Over the last 30 years, the NIH has helped lead development of numerous antiretroviral therapies. Azidothymidine (AZT), the first drug discovered to inhibit HIV’s replication without damaging cells, was initially developed by the NIH as an anti-cancer drug in the 1960s. Its use as an antiretroviral, approved by the FDA in 1987, helped to establish the AIDS Clinical Trials Group (ACTG), which further accelerated research into nucleoside reverse transcriptase inhibitors (NRTIs, the class of drug to which AZT belongs). NIAID-funded studies in the 1990s helped establish combination therapies, which combine multiple medications for a synergistic effect, and explored a newly-identified class of drug, non-nucleoside reverse transcriptase inhibitors or NNRTIs.

NIAID

Today, nearly three dozen antiretroviral drugs are available, many of them combined into fixed-dose tablets. In the 1990s, people living with AIDS would be expected to take up to 20 individual pills at set schedules throughout the day. The average lifespan for someone infected with the disease was roughly a year. Today, assuming you’re lucky enough to live in the developed world, AIDS has become a chronic condition to be controlled with a single daily pill. For the 20 million people living with AIDS but without access to modern treatment, it remains a death sentence.

The state of medical research technology has also evolved, even if the nation’s prevailing notions of fairness and equality haven't improved much in the intervening years since Reagan held power. Advances in laboratory standardization and automation have rapidly reduced development cycles and the occurrence of outlier results. The monotonous tasks that were once performed by lab assistants are now handled by robotic arms equipped with pipette arrays.

Disease prevention and diagnosis efforts have been augmented in recent years with artificial intelligence and machine learning algorithms. They’ve also found use in helping to stem the spread of HIV and improve access to both retrovirals and PReP with applications including, “ML with smartphone-collected and social media data to promote real-time HIV risk reduction, virtual reality tools to facilitate HIV serostatus disclosure, and chatbots for HIV education,” argue Drs. Julia Marcus and Whitney Sewell, of Harvard and UMass Amherst, respectively.

And just as Dr Fauci is, quite specifically, not retiring — “I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats,” he noted in Monday’s announcement — the work of the NIAID is far from complete. Even as we slowly conquer existing scourges like COVID and HIV, re-emerging threats like Monkeypox (not to mention ancient killers like Polio) will continue to appear on our quickly warming planet.

FDA greenlights over-the-counter hearing aids

Over-the-counter hearing aid sales should soon become a practical reality in the US. The Food and Drug Administration has issued a final rule allowing the sales of hearing aids for mild-to-moderate impairment without requirements for exams, prescriptions or audiologist fittings. The measure is expected to take effect in mid-October, when you should see aids reach physical retail stores.

You'll still need a prescription for severe hearing loss, or for anyone under 18. The FDA has also set design and performance requirements for over-the-counter aids, and has tweaked rules for prescriptions to ensure "consistency." The definitive rule comes in response to public and industry feedback, including lower maximum sound output, a requirement for user volume control and canal depth limits.

Congress first passed laws requiring over-the-counter hearing aids in 2017 in a bid to lower healthcare costs, improve access and spur competition. In theory, you would see more people wearing the devices as access and technology improve. However, the FDA didn't propose the necessary rule to fully implement the wearables until October 2021.

It could be awhile before there's a wide range of choices, but there are already offerings here or in the works. Lexie, for instance, recently began selling the $899 B1 using technology from Bose's reportedly defunct hearing aid division. Companies like Jabra have also leaped in early. The prices aren't trivial, but they're relative bargains when aids have historically cost thousands of dollars before insurance.

Scientists revived organ cells in dead pigs

Medical science is nowhere near overcoming death, but it might be closer to delaying harm in dying and seriously damaged organs. The New York Timesreports that Yale University researchers successfully revived cells in the organs of pigs that had been dead in the lab for an hour. Hearts started beating, and the pigs' bodies didn't stiffen like they normally would. 

The team mixed the animals' blood and an artificial hemoglobin with OrganEx, a solution that includes anti-inflammatory medicine, nerve blockers (to prevent a return to consciousness), nutrients and drugs that fight cell death. The project is a follow-up to a years-old breakthrough where the scientists revived dead pigs' brain cells using a precursor solution, BrainEx. After that finding, the group wondered if it could revive an entire body.

The work isn't close to helping human patients. Further studies will show if the organs are functioning. Researchers will also have to gauge the effects of OrganEx without nerve blockers, and eventually test their work on humans. There are ethical concerns that pigs might regain brain function, and it's not clear just when it would be viable to experiment with people. If synthetic blood isn't yet ready for emergency rooms, this is even further away.

The ramifications could be huge if and when solutions like OrganEx are suitable for humans, though. They could extend the viability of organ transplants — it might be possible to collect healthy organs long after the moment of death. That, in turn, could make more transplants available and save additional lives. The technology could also limit the damage to organs after serious heart attacks and strokes. Ideally, this will give people a fighting chance to recover from potentially fatal conditions.

Nearly 600 more TV writers call for Netflix, Apple to detail abortion safety policies

Last week, more than 400 TV showrunners, writers and producers called on streaming giants and traditional Hollywood studios to offer improved protections for workers in states where abortions are banned or limited. Now, 594 other industry figures (many, if not all of whom are male) have pledged their support, as Variety reports. They include Jordan Peele, Taika Waititi, Jason Sudekis, Ryan Murphy, Donald Glover and JJ Abrams.

The signatories said they were standing in solidarity with their “female, trans and non-binary showrunner colleagues [...] in demanding a coordinated and timely response from our employers regarding the imminent workplace-safety crisis created by the overturning of Roe v. Wade. Abortion access doesn’t only affect people who can become pregnant. It affects us all."

In late June, the US Supreme Court overturned Roe v. Wade, a ruling that conferred a nationwide right to abortion for almost half a century. Numerous states banned or severely restricted abortion access after the decision.

The initial letter was signed by the likes of Issa Rae, Lilly Wachowski, Lena Waithe, Amy Schumer, Shonda Rhimes, Mindy Kaling and Ava DuVernay. It was sent to Disney, Netflix, Warner Bros. Discovery, Paramount, Apple, NBC Universal, Amazon, Lionsgate and AMC.

The more than 1,000 industry figures who sent the letters are calling for details about studios' abortion travel subsidies, care policies for “ectopic pregnancies and other pregnancy complications” that occur during a production and legal safeguards for those who help a production worker get an abortion. The signatories also demanded that studios “discontinue all political donations to anti-abortion candidates and political action committees immediately.”

Those who signed the letters want the studios to respond by August 10th. The letters did not detail what may happen if the companies don't reply by then. Studios have previously said they would reimburse travel expenses for those who had to leave a state to get an abortion.

Thanks to its generous tax incentives for film and TV productions, Georgia has become a powerhouse in the entertainment industry, which is worth billions of dollars to the local economy. In 2019, several studios, including Netflix, said they'd reconsider setting up projects in the state if a so-called heartbeat law came into effect (the legislation bans abortions after a fetal heartbeat can be detected). A federal appeals court allowed the law to take effect last month.